콘텐츠로 건너뛰기
Merck

Strategies for simultaneous and successive delivery of RNA.

Journal of molecular medicine (Berlin, Germany) (2020-11-05)
Hanieh Moradian, Andreas Lendlein, Manfred Gossen
초록

Advanced non-viral gene delivery experiments often require co-delivery of multiple nucleic acids. Therefore, the availability of reliable and robust co-transfection methods and defined selection criteria for their use in, e.g., expression of multimeric proteins or mixed RNA/DNA delivery is of utmost importance. Here, we investigated different co- and successive transfection approaches, with particular focus on in vitro transcribed messenger RNA (IVT-mRNA). Expression levels and patterns of two fluorescent protein reporters were determined, using different IVT-mRNA doses, carriers, and cell types. Quantitative parameters determining the efficiency of co-delivery were analyzed for IVT-mRNAs premixed before nanocarrier formation (integrated co-transfection) and when simultaneously transfecting cells with separately formed nanocarriers (parallel co-transfection), which resulted in a much higher level of expression heterogeneity for the two reporters. Successive delivery of mRNA revealed a lower transfection efficiency in the second transfection round. All these differences proved to be more pronounced for low mRNA doses. Concurrent delivery of siRNA with mRNA also indicated the highest co-transfection efficiency for integrated method. However, the maximum efficacy was shown for successive delivery, due to the kinetically different peak output for the two discretely operating entities. Our findings provide guidance for selection of the co-delivery method best suited to accommodate experimental requirements, highlighting in particular the nucleic acid dose-response dependence on co-delivery on the single-cell level.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
5-Methylcytidine, ≥99%
제품번호
팩 크기
재고 정보
가격
수량
Sigma-Aldrich
Pseudouridine, ≥98% (HPLC)
제품번호
팩 크기
재고 정보
가격
수량